1-1 of 1
Edward Philpot
Close
Sort by
Journal Articles

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Alternative Pathway Masp-3 Inhibitor OMS906 in a Phase 1 Study of Healthy Subjects

William Pullman, Jane Humphreys, Edward Philpot, W. Jason Cummings
Journal: Blood
Blood (2022) 140 (Supplement 1): 5801–5802.
https://doi.org/10.1182/blood-2022-162828
Published: 2022